Urothelial carcinoma is associated with a high rate of recurrence with guidelines recommending rigorous, regular surveillance programs that are invasive and expensive. This study describes a non-invasive urine test with sufficient sensitivity to 'rule out' recurrent urothelial carcinoma, thereby reducing invasive diagnostic evaluations without compromising patient care.